UNITUXIN (DINUTIXIMAB) 17.5 MG/5 ML INJECTION

Unituxin (dinutuximab) is a chimeric monoclonal antibody composed of murine variable heavy and light chain regions and the human constant region for the heavy chain IgG1 and light chain kappa. Unituxin binds to the glycolipid disialoganglioside (GD2). Dinutuximab is produced in the murine myeloma cell line, SP2/0.

Unituxin (Dinutuximab) Injection suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

SOURCING:

Alleviare Life Sciences connects the buyer with the supplier who can ship Unituxin (Dinutuximab) (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Unituxin (Dinutuximab) is manufactured by United Therapeutics Corporation.

Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for Unituxin (Dinutuximab) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Unituxin (dinutuximab) is indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2) and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.

Verify that patients have adequate hematologic, respiratory, hepatic, and renal function prior to initiating each course of Unituxin.

Administer required premedication and hydration prior to initiation of each Unituxin infusion.

Medicine Name:Unituxin
Generic Name: Dinutuximab
Approval Date: 2015
Available as (Form & Strength): Injection: 17.5 mg / 5 ml , 3.5mg/ml | Single Use Vial, Discard Unused Portion
Company Name: United Therapeutics Corporation